Revelyx received tens of millions of dollars in Series A funding
36Kr learned that Revelyx Bio Inc. (hereinafter referred to as "Revelyx") has recently completed a Series A financing of tens of millions of dollars. This round of financing was exclusively led by NRL Capital, and the raised funds will be used to advance the clinical research and commercial expansion of the company's products globally
Source: 36Kr The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments